Sibel Health

Share on social media
On site

Sibel Health

Sibel Health is an award-winning medical technology company focused on delivering better health data for all through advanced sensor development, novel data analytics, and cloud computing. Sibel is commercializing ANNE One – the world’s first ICU-grade wearable monitoring platform for all ages – which has now been deployed worldwide in partnership with large medical technology, philanthropic, pharmaceutical, and insurer partners. Steve Xu MD, MSc is a physician-engineer, board-certified dermatologist, and innovator. He is currently the CEO of Sibel Health, Medical Director of the Querrey Simpson Institute for Bioelectronics at Northwestern University, and Assistant Professor in the Departments of Biomedical Engineering, Dermatology and Pediatrics at Northwestern University. Dr. Xu has authored more than 100 peer-reviewed publications and listed as an inventor on 13 pending and granted patents in the area of digital medicine. His publications have appeared in The New England Journal of Medicine, Science, Nature, and the Proceedings of the National Academies of Sciences garnering press attention from sources such as The New York Times, CNN, The Washington Post, and the BBC. As part of his collaborative research efforts, several of his inventions have been licensed to early stage companies commercializing the core technology. He received his undergraduate degree in bioengineering from Rice University summa cum laude. He completed his medical training at Harvard Medical School with special honors as a Soros Fellow, and a Masters in Health Policy and Finance with Merit from The London School of Economics as a Marshall Scholar. Finally, he completed an NIH-funded post-doctoral fellowship in Northwestern’s Department of Materials Science and Engineering under Professor John Rogers.
Share on social media

Agenda

Events to be announced
Sign up for for the Curious Future Insight Newsletter

Future Insight e.V. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Imprint/Privacy Statement. By clicking submit below, you consent to allow Future Insight e.V. to store and process the personal information submitted above to provide you the content requested.

EARLY-BIRD discount: Book your Curious2024 tickets and automatically receive 10% off prices – buy now!

Cookies

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the app and the website, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.